507P Biomarker assessment in ROS1+ NSCLC

Mendelian randomization also suggested a causal role for specific proteins in lung cancer development. Conclusions:Our findings establish that lung cancer evolves through a dynamic sequence of protein changes.This provides a new model for understanding prediagnostic disease, and our 9-protein signature is a powerful tool for precision screening to identify individuals with active disease progression.Legal entity responsible for the study: The authors.